Lefamulin Efficacy and Safety in Adults with Community-Acquired Bacterial Pneumonia (CABP): Pooled Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Trials in Patients with Asthma or Chronic Obstructive Lung Disease (COPD)

被引：0
|
作者：
Sandrock, C. E. [1 ]
Mariano, D. [2 ]
Gelone, S. P. [2 ]
Moran, G. J. [3 ]
Waterer, G. W. [4 ]
File, T. M. [5 ]
机构：
[1] Univ Calif Davis, Med Ctr, Sacramento, CA USA
[2] Nabriva Therapeut, Ft Washington, PA USA
[3] Olive View UCLA Med Ctr, Los Angeles, CA USA
[4] Univ Western Australia, Med Sch, Perth, Australia
[5] Summa Hlth, Akron, OH USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3447
引用
收藏
页数：1
相关论文
共 19 条
  • [1] LEFAMULIN EFFICACY AND SAFETY IN ADULTS WITH COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA: POOLED ANALYSIS OF THE LEFAMULIN EVALUATION AGAINST PNEUMONIA (LEAP) 1 AND LEAP 2 TRIALS IN PATIENTS WITH MULTILOBAR OR UNILOBAR PNEUMONIA
    File, Thomas
    Mariano, David
    Gelone, Steven
    Moran, Gregory
    Waterer, Grant
    Sandrock, Christian
    CHEST, 2021, 160 (04) : 522A - 523A
  • [2] LEFAMULIN EFFICACY AND SAFETY IN ADULTS WITH COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA: POOLED ANALYSIS OF THE LEFAMULIN EVALUATION AGAINST PNEUMONIA (LEAP) 1 AND LEAP 2 TRIALS BY AGE, INCLUDING IN PATIENTS AGED ≥85 YEARS
    Alexander, Elizabeth
    Goldberg, Lisa
    Meads, Andrew
    Gelone, Steven
    Sandrock, Christian
    Schranz, Jennifer
    CHEST, 2020, 158 (04) : 317A - 318A
  • [3] Pooled microbiological findings and efficacy outcomes by pathogen in adults with community-acquired bacterial pneumonia from the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 phase 3 trials of lefamulin versus moxifloxacin
    Paukner, Susanne
    Goldberg, Lisa
    Alexander, Elizabeth
    Das, Anita F.
    Heinrich, Stefanie
    Patel, Pritty
    Moran, Gregory J.
    Sandrock, Christian
    File Jr, Thomas M.
    Vidal, Jorge E.
    Waites, Ken B.
    Gelone, Steven P.
    Schranz, Jennifer
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2022, 29 : 434 - 443
  • [4] EFFICACY AND SAFETY OF LEFAMULIN IN CHINESE ADULTS WITH COMMUNITY-AQUIRED BACTERIAL PNEUMONIA (CABP): RESULTS OF LEFAMULIN EVALUATION AGAINST PNEUMONIA (LEAP-CHINA) STUDY
    Huang, Haihui
    Yuan, Rae
    Zhang, Yingyuan
    Ding, Jie
    Matsukami, Hirokazu
    CHEST, 2023, 164 (04) : 775A - 775A
  • [5] EFFICACY OF LEFAMULIN VS MOXIFLOXACIN IN ADULTS WITH COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA: RESULTS OF THE LEFAMULIN EVALUATION AGAINST PNEUMONIA (LEAP) 1 AND LEAP 2 DOUBLE-BLIND NONINFERIORITY PHASE-3 CLINICAL TRIALS
    Sandrock, Christian
    Schranz, Jennifer
    Goldberg, Lisa
    Alexander, Elizabeth
    Moran, Gregory
    Shorr, Andrew
    Gelone, Steven
    CHEST, 2019, 156 (04) : 418A - 419A
  • [6] SAFETY AND TOLERABILITY OF LEFAMULIN VS MOXIFLOXACIN IN ADULTS WITH COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA: RESULTS OF THE LEFAMULIN EVALUATION AGAINST PNEUMONIA (LEAP) 1 AND LEAP 2 DOUBLE-BLIND NONINFERIORITY PHASE-3 CLINICAL TRIALS
    Sandrock, Christian
    Schranz, Jennifer
    Goldberg, Lisa
    Alexander, Elizabeth
    Moran, Gregory
    Shorr, Andrew
    Gelone, Steven
    CHEST, 2019, 156 (04) : 1127A - 1128A
  • [7] EFFICACY AND SAFETY OF LEFAMULIN VS MOXIFLOXACIN FOR ATYPICAL RESPIRATORY PATHOGENS IN ADULTS WITH COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA: POOLED RESULTS FROM THE LEFAMULIN EVALUATION AGAINST PNEUMONIA (LEAP) 1 AND LEAP 2 DOUBLE-BLIND NONINFERIORITY PHASE-3 CLINICAL TRIALS
    Shorr, Andrew
    Schranz, Jennifer
    Goldberg, Lisa
    Paukner, Susanne
    Alexander, Elizabeth
    Moran, Gregory
    Sandrock, Christian
    Gelone, Steven
    CHEST, 2019, 156 (04) : 1133A - 1134A
  • [8] Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial
    File, Thomas M., Jr.
    Goldberg, Lisa
    Das, Anita
    Sweeney, Carolyn
    Saviski, John
    Gelone, Steven P.
    Seltzer, Elyse
    Paukner, Susanne
    Wicha, Wolfgang W.
    Talbot, George H.
    Gasink, Leanne B.
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (11) : 1856 - 1867
  • [9] LEFAMULIN EFFICACY IN ADULTS WITH COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA (CABP) IS UNAFFECTED BY OBESITY: POOLED ANALYSIS OF THE LEFAMULIN PHASE 3 CLINICAL TRIAL PROGRAM
    File, Thomas M.
    Beegle, Scott
    Crandon, Jared
    Varon, Joseph
    Mariano, David
    Gupta, Rohit
    Rali, Parth
    Guico-Pabia, Christine
    Sandrock, Christian E.
    CHEST, 2022, 162 (04) : 307A - 308A
  • [10] ORAL 5-DAY LEFAMULIN FOR OUTPATIENT MANAGEMENT OF COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA: POST-HOC ANALYSIS OF THE LEFAMULIN EVALUATION AGAINST PNEUMONIA (LEAP) 2 TRIAL
    LoVecchio, Frank
    Schranz, Jennifer
    Alexander, Elizabeth
    Mariano, David
    Meads, Andrew
    Sandrock, Christian
    Moran, Gregory J.
    Giordano, Philip A.
    JOURNAL OF EMERGENCY MEDICINE, 2021, 60 (06): : 781 - 792
12